Skip to main content
Log in

Vasoactive intestinal peptide (VIP) mediates the effect of estrogens on the dopaminergic tone in the hypothalamic-pituitary axis of ovariectomized (OVX) rats

  • Original Articles
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The role of vasoactive intestinal peptide (VIP) in the regulation of dopamine (DA) concentration in mediobasal hypothalamus (MBH), posterior and anterior pituitary of ovariectomized (OVX) estrogenized rats was studied using passive immunization against VIP with a specific antiserum (a-VIP). Chronic estradiol administration decreased DA concentration in MBH, and in posterior and anterior pituitary, compared to OVX control rats. DA tissue concentration increased following a-VIP administration to control and estrogenized OVX rats. In vitro study of VIP and a-VIP on DA release from MBH in chronically estrogenized OVX rats showed that estrogens decreased DA evoked-release from MBH; a-VIP increased DA evoked-release from MBH of control OVX and estrogenized rats. VIP decreased DA evoked-release from MBH of OVX rats, but had no effect on estrogenized rats. VIP decreased DA tissue concentration in MBH of OVX control but not of estrogenized rats. It is suggested that VIP decreases DA synthesis and release from hypothalamic neurons in female rats, and that VIP partially mediates the inhibitory effect of long-term estrogen administration on DA release from MBH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kordon, C., Drouva, S. V., Martinez de la Escalera, G., and Weiner, R. I. (1994). In:The physiology of reproduction. Knobil, E. and Neill, D. J. (eds.). Raven: New York.

    Google Scholar 

  2. Enjalbert, A., Arancibia, S., Ruberg, M., Priam, M., Blue-Pajot, M., Rotsztejn, W. H., and Kordon, C. (1980).Neuroendocrinology 31, 200–204.

    PubMed  CAS  Google Scholar 

  3. Matsushita, N., Kato, Y., Shimatzu, A., Katakami, H., Yanaihara, N., and Imura, H. (1983).Life Sci. 32, 1263–1269.

    Article  PubMed  CAS  Google Scholar 

  4. Haislander, D. J., Moy, J. A., Gala, R. R., and Lawson, D. M. (1988).Proc. Soc. Exp. Med. 187, 341–349.

    Google Scholar 

  5. Lam, K. S. L. (1991).Neuroendocrinology 53, 45–51.

    PubMed  CAS  Google Scholar 

  6. Nagy, G., Mulchahey, J. J., and Neill, J. D. (1988).Endocrinology 122, 364–366.

    PubMed  CAS  Google Scholar 

  7. Steel, J. H., Gon, G., O'Halloran, D. J., Jones, P. M., Yanaihara, N., Ishikawa, H., Bloom, S. R., and Polak, J. M. (1989).Histochemistry 93, 183–189.

    Article  PubMed  CAS  Google Scholar 

  8. Lasaga, M., Duvilanski, B. H., Seilicovich, A., Afione, S., Díaz, M. C., Pisera, D., Traktenberg, R., and Debeljuk, L. (1991).J. Neuroendocrinol. 3, 75–78.

    Article  CAS  PubMed  Google Scholar 

  9. Gozes, I. and Shani, Y. (1986).Endocrinology 119, 2497–2501.

    PubMed  CAS  Google Scholar 

  10. Rostene, W., Dussaillant, M., Denis, P., Gozes, I., Montagne, M., and Berod, A. (1992).Biomed. Res. 13, 63–69.

    Google Scholar 

  11. Mezey, E. and Kiss, J. Z. (1985).Proc. Natl. Acad. Sci. USA 2, 245–247.

    Article  Google Scholar 

  12. Lasaga, M., Debeljuk, L., Afione, S., Torres-Aleman, I., and Duvilanski, B. H. (1989).Neuroendocrinology 49, 574–579.

    PubMed  CAS  Google Scholar 

  13. Itoh, S., Katsuura, G., and Takashima, A. (1988).Peptides 9, 315–317.

    Article  PubMed  CAS  Google Scholar 

  14. Duvilanski, B. H., Lasaga, M., Seilicovich, A., Afione, S., Díaz, M. C., and Debeljuk, L. (1990).Brain Res. Bull. 25, 215–219.

    Article  PubMed  CAS  Google Scholar 

  15. Ben-Jonathan, N. (1985).Endocr. Rev. 6, 564–589.

    Article  PubMed  CAS  Google Scholar 

  16. Dluzen, D., Attaran, M., and Liu, B. J. (1994).Endocrinol. Invest. 17, 855–860.

    CAS  Google Scholar 

  17. Huang, S. K. and Pan J. T. (1996).Neuroendocrinology 64, 208–214.

    PubMed  CAS  Google Scholar 

  18. Abe, H., Engler, D., Molitch, M. E., Bollinger-Gruber, J., and Reichlin, S. (1985).Endocrinology 116, 1383–1390.

    PubMed  CAS  Google Scholar 

  19. Kaji, H., Chihara, K., Kita, T., Kashio, Y., Okimura, Y., and Fujita, T. (1985).Neuroendocrinology 41, 529–531.

    PubMed  CAS  Google Scholar 

  20. Murai, I., Reichlin, S., and Ben Jonathan, N. (1989).Endocrinology 124, 1050–1055.

    PubMed  CAS  Google Scholar 

  21. Shimatsu, A., Kato, Y., Matsushita, N., Katakami, H., Ohta, H., Yanaihara, N., and Imura, H. (1983).Endocrinology 113, 2059–2064.

    PubMed  CAS  Google Scholar 

  22. Tanimoto, K., Tamminga C. A., Chase, T. N., and Nilavev, G. (1987).Endocrinology 121, 127–132.

    PubMed  CAS  Google Scholar 

  23. Koshiyama, H., Kato, Y., Inoue, T., Murakami, Y., Ishikawa, Y., Yanaihara, N., and Imura, H. (1987).Neurosci. Lett. 75, 49–54.

    Article  PubMed  CAS  Google Scholar 

  24. Samson, W. K., Bianchi, R., Mogg, R. J., Rivier, J., Vale, W., and Melin, P. (1989).Endocrinology 124, 812–819.

    Article  PubMed  CAS  Google Scholar 

  25. Balsa, J. A., Cacicedo, L., Lara, J. I., Lorenzo, M. J., Pazos, F., and Sanchez-Franco, F. (1996).Endocrinology 137, 144–150.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mercedes Lasaga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasaga, M., Seilicovich, A., Pisera, D. et al. Vasoactive intestinal peptide (VIP) mediates the effect of estrogens on the dopaminergic tone in the hypothalamic-pituitary axis of ovariectomized (OVX) rats. Endocr 6, 53–56 (1997). https://doi.org/10.1007/BF02738802

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02738802

Key Words

Navigation